Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Blaine SK, Milivojevic V, Fox H, Sinha R (2016). Alcohol effects on stress pathways: impact on craving and relapse risk. Can J Psychiatry 61: 145–153.
Edwards S, Guerrero M, Ghoneim OM, Roberts E, Koob GF (2012). Evidence that vasopressin V1b receptors mediate the transition to excessive drinking in ethanol-dependent rats. Addict Biol 17: 76–85.
Lovallo WR, Dickensheets SL, Myers DA, Thomas TL, Nixon SJ (2000). Blunted stress cortisol response in abstinent alcoholic and polysubstance-abusing men. Alcohol Clin Exp Res 24: 651–658.
Ryan ML, Falk DE, Fertig JB, Rendenbach-Mueller B, Katz DA, Tracy KA et al (2016). A phase 2, double-blind, placebo-controlled randomized trial assessing the efficacy of ABT-436, a novel V1b receptor antagonist, for alcohol dependence. Neuropsychopharmacology (this issue).
Sinha R, Shaham Y, Heilig M (2011a). Translational and reverse translational research on the role of stress in drug craving and relapse. Psychopharmacology (Berl) 218: 69–82.
Sinha R, Fox HC, Hong KI, Hansen J, Tuit K, Kreek MJ (2011b). Effects of adrenal sensitivity, stress- and cue-induced craving, and anxiety on subsequent alcohol relapse and treatment outcomes. Arch Gen Psychiatry 68: 942–952.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Milivojevic, V., Sinha, R. Targeting Stress Pathophysiology to Improve Alcoholism Relapse Outcomes. Neuropsychopharmacol 42, 987–988 (2017). https://doi.org/10.1038/npp.2016.234
Published:
Issue date:
DOI: https://doi.org/10.1038/npp.2016.234